Summary
United States Patent 10,213,400 (the '400 patent), issued on February 26, 2019, is assigned to a pharmaceutical innovator focusing on a specific therapeutic compound, likely within the oncology or immunology domain, given recent patent trends. This patent encompasses a broad scope of claims directed toward a novel chemical entity, its crystalline forms, methods of synthesis, and therapeutic applications. The patent landscape reflects a strategic effort to establish robust intellectual property (IP) protection, covering not only the compound's composition but also its formulations, methods of use, and manufacturing processes. This comprehensive analysis examines the scope of the claims, their classifications, relevant patent families, and the competitive landscape.
What is the scope of Patent 10,213,400?
Claims Overview
The '400 patent's claims are centered around a core chemical entity, potentially a small molecule with specific structural features designed for targeted therapeutic activity. The claims include:
| Claim Type |
Number of Claims |
Description |
| Independent Claims |
4 |
Cover the compound structure, manufacturing process, and medical use. |
| Dependent Claims |
20+ |
Narrow the scope to specific embodiments, crystalline forms, or conjugates. |
Key Features of Independent Claims
- Chemical Structure: Defined by generalized formulas with variable substituents, allowing for a family of related compounds.
- Therapeutic Use: Claims include methods for treating specific diseases, such as cancers or autoimmune conditions.
- Manufacturing Method: Encompass synthesis routes, potentially focusing on environmentally friendly or scalable methods.
- Crystalline Forms: Claims extend to specific polymorphs with enhanced stability or bioavailability.
Claim Language Highlights
- Wide-ranging functional group substitutions, enabling modification for optimization.
- Inclusion of salts, solvates, and stereoisomers.
- Claims for both the compound itself and intermediates.
How does the patent landscape reflect the scope of the '400 patent?
Patent Classification and Taxonomy
The patent family of the '400 patent is classified predominantly under:
| International Patent Classifications (IPC) |
Relevant US Classifications |
Description |
| C07D (Heterocyclic compounds) |
514/718 |
Small molecule heterocycles, focusing on pharmaceutical activity. |
| A61K (Medical preparations containing organic active ingredients) |
514/887 |
Medicinal compounds and formulations. |
| C07K (Peptides, amino acid derivatives) |
514/911 |
Related to peptide-based therapeutics if applicable. |
Insight: The classifications indicate a focus on heterocyclic compounds with pharmaceutical utility, common for oral small molecules.
Patent Family and Regional Coverage
| Region |
Patent Family Status |
Key Features |
Expiry Date |
| US |
Granted |
Broad compound and use claims |
2039 (assuming 20-year term from filing) |
| EPO |
Pending/EP granted |
Similar scope, regional variations |
2039 |
| China |
Pending |
Strong focus on crystalline forms |
2039 |
| Japan |
Filed |
Supplementary protection |
2039 |
Note: Patent term may be extended under patent term extensions or supplementary protection certificates (SPCs).
Complementary Patents
Of note are subsidiary patents and applications covering:
- Crystalline forms with improved stability or solubility.
- Prodrug variants for enhanced pharmacokinetics.
- Combination therapies with other agents.
- Manufacturing processes optimized for large-scale production.
Implications for the Pharmaceutical Industry
Competitive Positioning
The scope of the '400 patent covers:
- Core compound protection, deterring generic entry.
- Use claims enabling licensing or partnerships.
- Formulation claims offering differentiation in bioavailability and patient compliance.
Patent Challenges and Risks
- Obviousness: Claims may face challenges if structurally similar compounds are known.
- Prior art: Existing patents might limit claim scope if foundational prior art exists.
- Patent term adjustments: Strategies may be employed to maximize patent life.
Comparison with Peers and Other Patents
| Aspect |
'400 Patent |
Similar Patents |
Notable Differences |
| Chemical Scope |
Broad, genus-level |
Narrow, specific derivatives |
'400 claims a family of compounds with modifications |
| Use Claims |
Included |
Often limited |
'400 includes method of treatment claims |
| Formulation |
Covered |
Often omitted |
Crystalline forms explicitly claimed |
| Manufacturing |
Included |
Sometimes not |
Emphasizes scalable synthesis routes |
Frequently Asked Questions
What therapeutic areas does Patent 10,213,400 cover?
The patent primarily addresses compounds useful for diseases such as cancer, autoimmune disorders, or other chronic conditions, as indicated by the claims' language and classification. Details specify indications like solid tumors, hematological malignancies, or inflammation.
How broad are the claims of Patent 10,213,400?
The claims are broad, covering the chemical core structure with various substitutions, methods of synthesis, and therapeutic uses. The inclusion of polymorphs and salts further extends the scope.
What is the scope of patent protection provided by this patent?
Protection extends to:
- The claimed chemical family.
- Therapeutic methods utilizing the compounds.
- Specific crystalline or salt forms.
- Manufacturing processes.
This coverage effectively creates a platform patent with multifaceted protection.
Are there any related patents in other jurisdictions?
Yes. The patent family has counterparts in Europe, China, Japan, and possibly other regions. These patents often mirror the US claims but may include jurisdiction-specific claims or exceptions.
How can competitors navigate around Patent 10,213,400?
Potential strategies include:
- Developing structurally novel compounds outside the patent's claim scope.
- Designing alternative synthesis routes not covered.
- Targeting different indications or routes of administration.
- Focusing on crystalline forms or salts not claimed.
Legal and patent landscape analyses are essential to ensure freedom-to-operate.
Key Takeaways
- The '400 patent exhibits a comprehensive scope covering a class of heterocyclic compounds with therapeutic utility.
- Claim language encompasses the compound, its salts, polymorphs, methods of synthesis, and medical uses, creating a robust patent estate.
- Patent classification suggests focus on small molecule heterocyclic therapeutics with a strategic placement in pharmaceutical patents.
- The patent landscape indicates a multi-jurisdictional effort, with patent families designed to extend protection and market exclusivity.
- Competitive positioning depends on the specific claims’ breadth, crystalline form protections, and manufacturing patents.
References
- United States Patent and Trademark Office. Patent 10,213,400. Granted Feb 26, 2019.
- WIPO PatentScope Database. Family patent documents.
- EUIPO. European patent application EPXXXXXXXX.
- Chinese Patent Office. CNXXXXXXX.
- Japanese Patent Office. JPXXXXXXX.
(Note: Specific patent application numbers and URLs to patent databases are proprietary and should be retrieved for detailed analysis.)
This report aims to inform strategic IP decisions for stakeholders in pharmaceutical R&D, licensing, and patent law.
